Press Release 2022 - Sami-Sabinsa Group | Formerly Known as Sami Labs Limited

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.

Sami-Sabinsa Europe Reports Strong Interest in New Product Innovation at FiE Show

Sami-Sabinsa To Highlight New Products, Established Category Leaders, and Immune Support Ingredients at SupplySide West

Sami-Sabinsa To Exhibit at UK Primary Care Pharmacy Trade Show

Sami-Sabinsa Japan to Exhibit at Health ingredients (Hi) Japan 2022 With Focus on Functional Foods

Sami-Sabinsa Group Highlighted Innovative Nutraceutical Ingredients at FiAsia in Jakarta, Indonesia

Sami-Sabinsa Group Named to Top 10 Pharma Laboratories by India Pharma Outlook

Certificates

Global Offices

Get in Touch

Disclaimer